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Background
Osteoarthritis (OA) affecting of the first metatarsopha-
langeal joint (MTPJ), is a common and painful condi-
tion. Although several different treatments have been
suggested throughout the literature, few have been ade-
quately evaluated. Therefore, the aim of this study was
to conduct a Cochrane review in order to determine the
efficacy of treatments available for first MTPJ OA.
Methods
Randomised controlled trials, quasi-randomised trials, or
controlled clinical trials that assessed treatment out-
comes for first MTPJ OA were searched for across sev-
eral electronic databases (to the 14th January 2010)
(CENTRAL; MEDLINE; EMBASE; CINAHL; and
PEDro). Participants of any age or gender with OA of
the first MTPJ defined either radiographically or clini-
cally were included in this review.
Results
Only one trial satisfactorily fulfilled the inclusion criteria
and was included in this review. This trial evaluated the
effectiveness of two physical therapy programs in 20
individuals with OA of the first MTPJ. Assessment out-
comes included pain levels, first MTPJ range of motion
and plantarflexion strength of the hallux. Mean differ-
ences at 4 weeks follow up were 3.80 points [95% CI:
2.74 to 4.86] for self reported pain, 28.30 degrees [95%
CI: 21.37 to 35.23] for first MTPJ range of motion and
2.80 kilograms [95% CI; 2.13 to 3.47] for muscle
strength. Although differences in outcomes between
treatment and control groups were reported, the risk of
bias was high. The trial failed to employ appropriate
randomisation or adequate allocation concealment, used
a relatively small sample and incorporated a short follow
up (4 weeks). No adverse reactions were reported.
Conclusions
Only one quasi-randomised controlled trial for first
MTPJ OA was found. The reviewed trial presented a
high risk of bias, limiting the conclusions that could be
drawn from the presented data. The inclusion of only
one trial indicates the need for more robust randomised
controlled trials to determine the efficacy of interven-
tions for this condition.
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